Signaling through TNF receptor p55 in TNF-α-deficient mice alters the CXCL13/CCL19/CCL21 ratio in the spleen and induces maturation and migration of anergic B cells into the B cell follicle

Journal of Immunology

Volumn 167, Issue 4, 2001, Pages 1920-1928

  Mandik Nayak, L ^a   Huang, G ^a   Sheehan, K C F ^a   Erikson, J ^a   Chaplin, D D ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CHEMOKINE; ANTINUCLEAR ANTIBODY; BETA CHEMOKINE; DOUBLE STRANDED DNA; LIGAND; LYMPHOTOXIN; MONOCLONAL ANTIBODY; PROTEIN P55; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE; CELL AGGREGATION; CELL MATURATION; CELLULAR DISTRIBUTION; CLONAL ANERGY; CONTROLLED STUDY; DENDRITIC CELL; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE MIGRATION; LYMPHOID TISSUE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SPLEEN; T LYMPHOCYTE;

EID: 0035881240     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.4.1920     Document Type: Article

References (60)

1. The changing preference of T and B cells for partners as T-dependent antibody responses develop
2. Follicular dendritic cells: Origin and function
3. Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin
4. Immune and inflammatory responses in TNFα-deficient mice: A critical requirement for TNFα in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response
5. Turning off follicular dendritic cells
6. Lymphotoxin but not tumor necrosis factor functions to maintain splenic architecture and humoral responsiveness in adult mice
7. Effects of tumor necrosis factor and lymphotoxin on peripheral lymphoid tissue development
8. Disrupted splenic architecture, but normal lymph node development in mice expressing a soluble lymphotoxin-β receptor-IgGI
9. Differentiation of follicular dendritic cells and full antibody responses require tumor necrosis factor receptor-1 signaling
10. Lymphotoxin-α-deficient mice: Effects on secondary lymphoid organ development and humoral immune responsiveness
11. Distinct roles for lymphotoxin-α and tumor necrosis factor in organogenesis and spatial organization of lymphoid tissue
12. A B-cell homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1
13. B cell-attracting chemokine I, a human CLC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5
14. Epstein-Barr virus-induced molecule 1 ligand chemokine is expressed by dendritic cells in lymphoid tissues and strongly attracts naive T cells and activated B cells
15. A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes
16. Lymphotoxin α/β and tumor necrosis factor are required for stromal cell expression of homing chemokines in B and T cell areas of the spleen
17. In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. I. The architecture and dynamics of responding cell populations
18. Sites of specific B cell activation in primary and secondary responses to T cell-dependent and T cell-independent antigens
19. Follicular dendritic cells: Antigen retention, B cell activation, and cytokine production
20. The site and stage of anti-DNA B cell deletion
21. Receptor editing: An approach by autoreactive B cells to escape tolerance
22. Regulation of anti-double-stranded DNA B cells in non-autoimmune mice: Localization to the T-B interface of the splenic follicle
23. Persistence of functionally compromised anti-dsDNA B cells in the periphery of non-autoimmune mice
24. Competition for follicular niches excludes self-reactive cells from the recirculating B-cell repertoire
25. MRL-lpr/lpr mice exhibit a defect in maintaining developmental arrest and follicular exclusion of anti-double-stranded DNA B cells
26. Follicular dendritic cell dysfunction and disorganization of lymphoid structures in MRL/lpr mice
27. Alterations in splenic architecture and the localization of anti-double-stranded DNA B cells in aged mice
28. Ig H and L chain contributions to autoimmune specificities
29. Breakdown of B cell tolerance in a mouse model of SLE
30. TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation
31. Characterization of tumor necrosis factor-deficient mice
32. Expression of anti-DNA immunoglobulin transgenes in non-autoimmune mice
33. Resolution and characterization of pro-B and pre-B cell stages in normal mouse bone marrow
34. Antinuclear antibodies: Diagnostic markers for autoimmune diseases and probes for cell biology
35. Monoclonal antibodies specific for murine p55 and p75 tumor necrosis factor receptors: Identification of a novel in vivo role for p75
36. high splenic B cells are an immature developmental intermediate in the production of long-lived marrow-derived B cells
37. CD22 is a negative regulator of B-cell receptor signalling
38. A molecular and immunochemical characterization of mouse CR2: Evidence for a single gene model of mouse complement receptors 1 and 2
39. HD39 (B3), a B lineage-restricted antigen whose cell surface expression is limited to resting and activated human B lymphocytes
40. Fcε receptor, a specific differentiation marker transiently expressed on mature B cells before isotype switching
41. High levels of CD44 expression distinguish virgin from antigen-primed B cells
42. Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice
43. Characterization of anti-single-stranded DNA B cells in a non-autoimmune background
44. Differences in susceptibility of mature and immature mouse B lymphocytes to anti-immunoglobulin-induced immunoglobulin suppression in vitro: Possible implications for B-cell tolerance to self
45. Receptor-mediated inactivation of early B lymphocytes
46. Immunoglobulin signal transduction guides the specificity of B cell-T cell interactions and is blocked in tolerant self-reactive B cells
47. Elimination of self-reactive B lymphocytes proceeds in two stages: Arrested development and cell death
48. Bcl-2 obstructs negative selection of autoreactive, hypermutated antibody V regions during memory B cell development
49. The origin of anti-nuclear antibodies in bcl-2 transgenic mice
50. Novel roles for Lyn in B cell migration and lipopolysaccharide responsiveness revealed using anti-double-stranded DNA Ig transgenic mice
51. Tumor necrosis factor and the p55TNF receptor are required for optimal development of the marginal sinus and for migration of follicular dendritic cell precursors into splenic follicles
52. Functional consequences of the developmental arrest and follicular exclusion of anti-double-stranded DNA B cells
53. Characterization of anergic anti-DNA B cells: B cell anergy is a T cell independent and potentially reversible process
54. The fate of self-reactive B cells depends primarily on the degree of antigen receptor engagement and availability of T cell help
55. Outer periarteriolar lymphoid sheath arrest and subsequent differentiation of both naive and tolerant immunoglobulin transgenic B cells is determined by B cell receptor occupancy
56. Antigen-induced exclusion from follicles and anergy are separate and complementary processes that influence peripheral B cell fate
57. B lymphocyte chemotaxis regulated in association with microanatomic localization, differentiation state, and B cell receptor engagement
58. Activation-dependent modulation of B lymphocyte migration to chemokines
59. Generation of splenic follicular structure and B cell movement in tumor necrosis factor-deficient mice
60. Two tumor necrosis factor receptors: Structure and function